Literature DB >> 33226398

Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019.

Marissa H Elliott1, Joshua J Skydel2, Sanket S Dhruva3, Joseph S Ross4, Joshua D Wallach5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33226398      PMCID： PMC7684521          DOI： 10.1001/jamainternmed.2020.4799

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials.

Authors:  Rubaya Yeahia; Renee L Gennarelli; Daniel J Morgan; Deborah Korenstein
Journal:  J Gen Intern Med       Date:  2021-08-11       Impact factor: 6.473

Review 2.  An urgent call to raise the bar in oncology.

Authors:  John-John B Schnog; Michael J Samson; Rijk O B Gans; Ashley J Duits
Journal:  Br J Cancer       Date:  2021-08-16       Impact factor: 7.640

3.  Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials.

Authors:  Ronald B Brown
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

4.  Clinician Conceptualization of the Benefits of Treatments for Individual Patients.

Authors:  Daniel J Morgan; Lisa Pineles; Jill Owczarzak; Larry Magder; Laura Scherer; Jessica P Brown; Chris Pfeiffer; Chris Terndrup; Luci Leykum; David Feldstein; Andrew Foy; Deborah Stevens; Christina Koch; Max Masnick; Scott Weisenberg; Deborah Korenstein
Journal:  JAMA Netw Open       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.